Counterfeit Drug
FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk and the FDA announced.
Scams, low-quality products a risk when ordering semaglutide from online pharmacies
Quality testing of three counterfeit semaglutide products found low purity and more measured semaglutide than what was on the label, according to a research letter published in JAMA Network Open.
FDA issues warnings to two companies for unapproved semaglutide, tirzepatide
The FDA has issued warning letters to two companies for offering unapproved and misbranded versions of semaglutide and tirzepatide on their websites, according to a press release.
Lilly warns public not to use tirzepatide for cosmetic weight loss
Eli Lilly and Co. released an open letter stating its tirzepatide products should not be used for cosmetic weight loss and warning the public about the circulation of compounded and counterfeit tirzepatide.